PTD-DBM: A Cell-Penetrating Peptide in Tissue-Regeneration Research
PTD-DBM is a synthetic peptide combining a protein transduction domain (PTD) — which enhances cell-membrane penetration — with a bone-morphogenetic-protein-derived motif. It is studied for its role in osteoblast differentiation and tissue-regeneration models.
What is PTD-DBM?
The peptide is designed to mimic bone morphogenetic protein (BMP) signaling while the PTD portion improves intracellular delivery across cell membranes. This combination makes it a research tool for studying regenerative signaling pathways at the cellular level.
Mechanism in research models
PTD-DBM is studied for stimulating osteoblast differentiation — osteoblasts being the cells responsible for bone formation. By engaging cellular receptors, it can trigger signaling cascades associated with bone growth and tissue repair in preclinical models.
Research areas
- Bone-regeneration models: fracture and bone-defect repair studies.
- Dental research: bone-growth models around implants and periodontal tissue.
- Soft-tissue repair: wound-healing model investigations.
- Orthopedic research: bone-fusion model studies.
Handling for Canadian research labs
- Not authorized by Health Canada for human use — laboratory research only. Much of the evidence is early-stage (animal models).
- Store lyophilized at −20°C; reconstitute with sterile bacteriostatic water using aseptic technique.
- Source from reputable suppliers providing third-party purity testing and a COA.
Explore related tissue-repair research compounds we carry: BPC-157, TB-500, and GHK-Cu — all third-party tested to over 99% purity with a COA. Pair with bacteriostatic water.
This guide is part of our Peptides Canada research hub — explore the full library of compound guides.
Disclaimer: Educational and research content only. PTD-DBM is discussed strictly as a research chemical, not for human consumption or therapeutic use. All work must comply with Canadian regulations and institutional ethics approvals.